Shulan (Hangzhou) Hospital

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Efficacy and Safety of Pegylated Interferon Alpha-2β in Patients With Hepatitis B-related Hepatocellular Carcinoma After Radical Resection	Blood-Borne Infections, Chronic Disease, DNA Virus Infections, Digestive System Diseases, Digestive System Neoplasms, Disease Attributes, Hepadnaviridae infectious disease, Hepatitis, Chronic, Infections, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, adenocarcinoma, carcinoma, chronic hepatitis B virus infection, epithelial neoplasm, hepatitis, hepatitis B virus infection, hepatocellular carcinoma, infectious disease, liver disorder, neoplasm, viral hepatitis, viral infectious disease	Not yet recruiting	Early phase 1	2026-04-28		NCT07553767
Efficacy and Safety of Recombinant Human FGF21-Fc Fusion Protein for Injection (TQA2225/AP025) in Adult Subjects With Non-alcoholic Steatohepatitis (NASH)	Digestive System Diseases, fatty liver disease, liver disorder, metabolic dysfunction-associated steatohepatitis, metabolic dysfunction-associated steatotic liver disease	Recruiting	Phase 2	2024-08-26		NCT06569524

Clinical trials